151 related articles for article (PubMed ID: 15117704)
1. Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis.
Freeman VL; Durazo-Arvizu R; Keys LC; Johnson MP; Schafernak K; Patel VK
Am J Public Health; 2004 May; 94(5):803-8. PubMed ID: 15117704
[TBL] [Abstract][Full Text] [Related]
2. Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems.
Freeman VL; Durazo-Arvizu R; Arozullah AM; Keys LC
Am J Public Health; 2003 Oct; 93(10):1706-12. PubMed ID: 14534226
[TBL] [Abstract][Full Text] [Related]
3. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987.
Pienta KJ; Demers R; Hoff M; Kau TY; Montie JE; Severson RK
Urology; 1995 Jan; 45(1):93-101; discussion 101-2. PubMed ID: 7817485
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in the impact of comorbidities on survival among elderly men with prostate cancer.
Putt M; Long JA; Montagnet C; Silber JH; Chang VW; Kaijun Liao ; Schwartz JS; Pollack CE; Wong YN; Armstrong K
Med Care Res Rev; 2009 Aug; 66(4):409-35. PubMed ID: 19357389
[TBL] [Abstract][Full Text] [Related]
5. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
6. Race and the histologic grade of prostate cancer.
Freeman VL; Leszczak J; Cooper RS
Prostate; 1997 Feb; 30(2):79-84. PubMed ID: 9051145
[TBL] [Abstract][Full Text] [Related]
7. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
8. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.
Daskivich TJ; Kwan L; Dash A; Greenfield S; Litwin MS
Eur Urol; 2014 Dec; 66(6):1002-9. PubMed ID: 24924554
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity and competing risks for mortality in men with prostate cancer.
Daskivich TJ; Chamie K; Kwan L; Labo J; Dash A; Greenfield S; Litwin MS
Cancer; 2011 Oct; 117(20):4642-50. PubMed ID: 21480201
[TBL] [Abstract][Full Text] [Related]
10. Impact of race on survival in men with metastatic hormone-refractory prostate cancer.
Halabi S; Small EJ; Vogelzang NJ; Barrier RC; George SL; Gilligan TD
Urology; 2004 Aug; 64(2):212-7. PubMed ID: 15302462
[TBL] [Abstract][Full Text] [Related]
11. Black-white differences in survival from late-stage prostate cancer.
Polednak AP
Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
[TBL] [Abstract][Full Text] [Related]
12. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation.
Austin JP; Convery K
Am J Clin Oncol; 1993 Apr; 16(2):140-5. PubMed ID: 8452106
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer incidence and mortality rates among white and black men.
Merrill RM; Brawley OW
Epidemiology; 1997 Mar; 8(2):126-31. PubMed ID: 9229202
[TBL] [Abstract][Full Text] [Related]
14. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.
Fowler JE; Bigler SA; Bowman G; Kilambi NK
J Urol; 2000 Jan; 163(1):137-42. PubMed ID: 10604331
[TBL] [Abstract][Full Text] [Related]
15. Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.
Moses KA; Chen LY; Sjoberg DD; Bernstein M; Touijer KA
BMC Urol; 2014 Dec; 14():98. PubMed ID: 25495177
[TBL] [Abstract][Full Text] [Related]
16. Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004.
Robbins AS; Yin D; Parikh-Patel A
Am J Epidemiol; 2007 Jul; 166(1):71-8. PubMed ID: 17426038
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in adenocarcinoma of the prostate in North American men.
Morton RA
Urology; 1994 Nov; 44(5):637-45. PubMed ID: 7526522
[TBL] [Abstract][Full Text] [Related]
18. The impact of race on freedom from prostate-specific antigen failure in prostate cancer patients treated with definitive radiation therapy.
Young CD; Lewis P; Weinberg V; Lee TT; Coleman CW; Roach M
Semin Urol Oncol; 2000 May; 18(2):121-6. PubMed ID: 10875452
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
[TBL] [Abstract][Full Text] [Related]
20. Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.
Wood HM; Reuther AM; Gilligan TD; Kupelian PA; Modlin CS; Klein EA
J Urol; 2007 Oct; 178(4 Pt 1):1271-6. PubMed ID: 17698101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
